POS0722 EFFECTS ON SOLUBLE IMMUNE CHECKPOINTS INDUCED BY TOCILIZUMAB MONOTHERAPY AFTER ULTRA-SHORT-TERM GLUCOCORTICOIDS IN LARGE VESSEL – GIANT CELL ARTERITIS PATIENTS | Publicación